[go: up one dir, main page]

NO318203B1 - Imidazopyridinderivater som inhiberer magesyresekresjon - Google Patents

Imidazopyridinderivater som inhiberer magesyresekresjon Download PDF

Info

Publication number
NO318203B1
NO318203B1 NO20005451A NO20005451A NO318203B1 NO 318203 B1 NO318203 B1 NO 318203B1 NO 20005451 A NO20005451 A NO 20005451A NO 20005451 A NO20005451 A NO 20005451A NO 318203 B1 NO318203 B1 NO 318203B1
Authority
NO
Norway
Prior art keywords
compound
formula
alkyl
ethyl
methylbenzylamino
Prior art date
Application number
NO20005451A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005451L (no
NO20005451D0 (no
Inventor
Ingemar Starke
Kosrat Amin
Mikael Dahlstrom
Peter Nordberg
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20005451D0 publication Critical patent/NO20005451D0/no
Publication of NO20005451L publication Critical patent/NO20005451L/no
Publication of NO318203B1 publication Critical patent/NO318203B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20005451A 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon NO318203B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000662 WO1999055705A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (3)

Publication Number Publication Date
NO20005451D0 NO20005451D0 (no) 2000-10-27
NO20005451L NO20005451L (no) 2000-12-27
NO318203B1 true NO318203B1 (no) 2005-02-14

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005451A NO318203B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon
NO20005450A NO317262B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon, farmasoytisk formulering som inneholder slike derivater, fremgangsmate for deres fremstilling, anvendelse derav, og mellomprodukter.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20005450A NO317262B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon, farmasoytisk formulering som inneholder slike derivater, fremgangsmate for deres fremstilling, anvendelse derav, og mellomprodukter.

Country Status (33)

Country Link
US (2) US6313136B1 (is)
EP (4) EP1073656B1 (is)
JP (2) JP3692034B2 (is)
KR (3) KR100595805B1 (is)
CN (2) CN1174980C (is)
AR (2) AR015769A1 (is)
AT (4) ATE312101T1 (is)
AU (2) AU769190B2 (is)
BR (2) BR9909995B1 (is)
CA (2) CA2329921A1 (is)
CZ (2) CZ293977B6 (is)
DE (4) DE69937076T2 (is)
DK (2) DK1073656T3 (is)
EE (2) EE04916B1 (is)
ES (2) ES2249913T3 (is)
HU (2) HUP0102425A3 (is)
ID (2) ID26819A (is)
IL (4) IL139297A0 (is)
IS (2) IS5683A (is)
MY (2) MY121389A (is)
NO (2) NO318203B1 (is)
NZ (2) NZ507638A (is)
PL (2) PL343797A1 (is)
RU (2) RU2235725C2 (is)
SA (2) SA99200065B1 (is)
SE (1) SE9801526D0 (is)
SI (1) SI1073656T1 (is)
SK (2) SK14912000A3 (is)
TR (4) TR200003176T2 (is)
TW (2) TW490466B (is)
UA (2) UA67769C2 (is)
WO (2) WO1999055705A1 (is)
ZA (2) ZA200005797B (is)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
PT1368006E (pt) * 2001-02-13 2006-08-31 Astrazeneca Ab Nova formulacao de libertacao modificada
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
CN100549011C (zh) 2002-09-19 2009-10-14 先灵公司 用作细胞周期蛋白依赖性激酶抑制剂的新颖咪唑并吡啶
NZ540504A (en) 2002-11-19 2007-12-21 Altana Pharma Ag 8-Substituted imidazopyridines for the treatment of gastrointestinal disorders
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
US7230098B2 (en) * 2003-02-26 2007-06-12 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20080280944A1 (en) * 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090291977A1 (en) * 2004-12-17 2009-11-26 Madoka Jinno Chromane Derivatives Useful As Acid Pump Antagonists
EP2258350B1 (en) 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
JP5206405B2 (ja) * 2005-03-21 2013-06-12 エムイーアイ・ファーマ・インコーポレイテッド イミダゾ[1,2−a]ピリジン誘導体:製造および医薬用途
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
TW200700064A (en) * 2005-03-24 2007-01-01 Glaxo Group Ltd Novel compounds
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
KR101146852B1 (ko) 2005-12-05 2012-05-16 화이자 프로덕츠 인크. C?met/hgfr 억제제의 다형체
BRPI0619424B1 (pt) 2005-12-05 2022-02-08 Pfizer Products Inc Uso de inibidores c-met/hgfrs para a fabricação de medicamentos
RU2008137145A (ru) * 2006-03-17 2010-03-27 Раквалиа Фарма Инк. (Jp) Производные хромана
WO2008013785A2 (en) 2006-07-24 2008-01-31 Singh-Broemer And Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
US8513226B2 (en) * 2008-03-31 2013-08-20 Council Of Scientific And Industrial Research Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
RU2403904C1 (ru) * 2009-02-26 2010-11-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Росздрава" Способ профилактики острых гастродуоденальных язв у больных колоректальным раком в раннем послеоперационном периоде
JP5802898B2 (ja) * 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
MX363456B (es) * 2013-06-25 2019-03-25 Hoffmann La Roche Compuestos para tratar atrofia muscular espinal.
KR20220112867A (ko) 2013-12-16 2022-08-11 에이비에스 디벨롭먼트 원 인코포레이티드 P2x3 및/또는 p2x2/3 화합물 및 방법
TWI662033B (zh) * 2014-03-24 2019-06-11 美商亞闊股份有限公司 製備3-(3-(4-(1-胺基環丁基)苯基)-5-苯基-3H-咪唑並[4,5-b]吡啶-2-基)吡啶-2-胺之方法
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
US11666888B2 (en) 2018-02-05 2023-06-06 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
EP3774719B1 (de) 2018-04-10 2025-07-23 Bayer Aktiengesellschaft Verfahren zur herstellung von 2,6-dialkylphenyl-essigsäuren
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
WO2021089580A1 (en) 2019-11-04 2021-05-14 Cinclus Pharma Ag Oral formulation of x842
JP2024542115A (ja) 2021-11-05 2024-11-13 シンクルス・ファーマ・ホールディング・アクチエボラグ リナプラザングルレートのメシラート塩の多形体
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
JP2026503095A (ja) 2023-01-11 2026-01-27 シンクルス・ファーマ・ホールディング・アクチエボラグ・パブリーク リナプラザングルレート(linaprazan glurate)の臭化水素酸塩の多形
JP2026503327A (ja) * 2023-02-01 2026-01-28 ジェイル ファーマシューティカル カンパニー リミテッド 医薬製剤、その製造方法及び錠剤用組成物
WO2025215593A1 (en) * 2024-04-12 2025-10-16 Hetero Labs Limited An improved process for preparation of zastaprazan
WO2026005543A1 (ko) * 2024-06-28 2026-01-02 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염의 결정형 및 이의 제조방법
WO2026005545A1 (ko) * 2024-06-28 2026-01-02 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
KR100595805B1 (ko) 2006-07-03
EP1073657A1 (en) 2001-02-07
CN1306533A (zh) 2001-08-01
EP1491543A1 (en) 2004-12-29
RU2235725C2 (ru) 2004-09-10
TR200102728T2 (tr) 2002-06-21
MY121389A (en) 2006-01-28
KR100595806B1 (ko) 2006-07-03
ES2249913T3 (es) 2006-04-01
HK1071139A1 (en) 2005-07-08
EP1073656A1 (en) 2001-02-07
KR20010043134A (ko) 2001-05-25
MY121379A (en) 2006-01-28
HUP0102425A2 (hu) 2001-11-28
CA2329922A1 (en) 1999-11-04
SA99200065B1 (ar) 2006-11-07
EP1073656B1 (en) 2005-10-19
EP1491542A2 (en) 2004-12-29
NO317262B1 (no) 2004-09-27
DE69937076D1 (de) 2007-10-18
ATE307130T1 (de) 2005-11-15
TWI250159B (en) 2006-03-01
RU2238271C2 (ru) 2004-10-20
CA2329921A1 (en) 1999-11-04
TR200102612T2 (tr) 2002-06-21
HK1036981A1 (en) 2002-01-25
KR20050121760A (ko) 2005-12-27
BR9909995A (pt) 2000-12-26
JP3692034B2 (ja) 2005-09-07
BR9909996A (pt) 2000-12-26
UA67769C2 (uk) 2004-07-15
BR9909996B1 (pt) 2010-08-24
HUP0102313A2 (hu) 2001-12-28
NZ507639A (en) 2004-01-30
AU4300699A (en) 1999-11-16
WO1999055705A1 (en) 1999-11-04
CZ293977B6 (cs) 2004-09-15
HUP0102313A3 (en) 2002-10-28
DE69927803T2 (de) 2006-07-06
TW490466B (en) 2002-06-11
CN1165535C (zh) 2004-09-08
NO20005450D0 (no) 2000-10-27
TR200003149T2 (tr) 2001-03-21
PL343797A1 (en) 2001-09-10
DE69937077T2 (de) 2008-05-29
IL139200A (en) 2010-04-29
CA2329922C (en) 2006-04-11
DK1073656T3 (da) 2006-01-16
SA99200065A (ar) 2005-12-03
CZ20003981A3 (cs) 2001-03-14
JP3883383B2 (ja) 2007-02-21
AU4300799A (en) 1999-11-16
HK1033317A1 (en) 2001-08-24
SK285768B6 (sk) 2007-07-06
BR9909995B1 (pt) 2010-07-13
PL343801A1 (en) 2001-09-10
ID26819A (id) 2001-02-15
JP2002513024A (ja) 2002-05-08
EP1073657B1 (en) 2005-12-07
KR100650472B1 (ko) 2006-11-28
DE69928792D1 (de) 2006-01-12
HUP0102425A3 (en) 2002-12-28
DE69937077D1 (de) 2007-10-18
UA66846C2 (uk) 2004-06-15
AR015768A1 (es) 2001-05-16
EE200000626A (et) 2002-04-15
HK1033457A1 (en) 2001-08-31
EE200000664A (et) 2002-04-15
EP1491542A3 (en) 2005-01-05
EE04676B1 (et) 2006-08-15
IL139297A0 (en) 2001-11-25
NO20005451L (no) 2000-12-27
SA99200064B1 (ar) 2006-10-11
EP1491543B1 (en) 2007-09-05
DE69937076T2 (de) 2008-05-29
EP1491542B1 (en) 2007-09-05
DE69927803D1 (de) 2006-03-02
US6313136B1 (en) 2001-11-06
IS5684A (is) 2000-10-25
ATE372340T1 (de) 2007-09-15
ZA200005797B (en) 2002-01-18
AR015769A1 (es) 2001-05-16
NO20005451D0 (no) 2000-10-27
SE9801526D0 (sv) 1998-04-29
AU769190B2 (en) 2004-01-22
ATE312101T1 (de) 2005-12-15
IL139200A0 (en) 2001-11-25
TR200003176T2 (tr) 2001-03-21
IS5683A (is) 2000-10-25
ID27530A (id) 2001-04-12
HK1036984A1 (en) 2002-01-25
KR20010043133A (ko) 2001-05-25
IL139297A (en) 2007-06-03
ATE372339T1 (de) 2007-09-15
NZ507638A (en) 2003-10-31
CZ292567B6 (cs) 2003-10-15
AU769108B2 (en) 2004-01-15
US6313137B1 (en) 2001-11-06
CN1307577A (zh) 2001-08-08
PL195000B1 (pl) 2007-07-31
CZ20003982A3 (cs) 2001-02-14
DK1073657T3 (da) 2006-03-13
DE69928792T2 (de) 2006-07-20
NO20005450L (no) 2000-12-22
JP2002513025A (ja) 2002-05-08
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
SK14912000A3 (sk) 2001-06-11
ZA200005796B (en) 2002-01-18
SK14922000A3 (sk) 2001-06-11
ES2252975T3 (es) 2006-05-16
EE04916B1 (et) 2007-10-15
WO1999055706A9 (en) 2000-03-16
CN1174980C (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
NO318203B1 (no) Imidazopyridinderivater som inhiberer magesyresekresjon
NO315704B1 (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse
CZ301499A3 (cs) Sloučeniny pro inhibici sekrece žaludeční kyseliny
NO311672B1 (no) Nye forbindelser, farmasöytisk preparat inneholdende slike forbindelser, deres anvendelser, og fremgangsmåter for deresfremstilling
MXPA00010231A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
HK1033457B (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
MXPA00010239A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
HK1033317B (en) Imidazo pyridine derivatives which inhibit gastric acid secretion

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees